Press Release

Vasopressin for Vasoplegic Shock Market to Hit USD 2,657.9 Million by 2027; Rising Cases of Cardiac Syndrome Globally: Fortune Business Insights™

The global “Vasopressin For Vasoplegic Shock Market”, size is expected to gain momentum by reaching USD 2,657.9 million by 2027, while exhibiting a stellar CAGR of 14.8% between 2020 and 2027. This is attributable to the increasing prevalence of cardiovascular surgeries that propels the demand for vasopressin for vasoplegic shock across the globe. This information is published by Fortune Business Insights, in its latest report, titled, “Vasopressin for Vasoplegic Shock Market Size, Share & COVID-19 Impact Analysis, By Application (Sepsis, Post Cardiac Surgery, and Others) Regional Forecast, 2020-2027.” The report further mentions that the market stood at USD 890.9 million in 2019.

Request a Sample Copy of the Research Report:

What does the Report Include?

The market report includes a detailed assessment of various drivers and restraints, opportunities, and challenges that the market will face during the projected horizon. Additionally, the report provides comprehensive insights into the regional developments of the market, affecting its growth during the forecast period. It includes information sourced from the advice of expert professionals from the industry by our research analysts using several research methodologies. The competitive landscape offers further detailed insights into strategies such as product launches, partnership, merger and acquisition, and collaborations adopted by the companies to maintain market stronghold between 2020 and 2027.

An Overview of the Impact of COVID-19 on this Market :

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.

For more information visit :

Rising Cardiac Syndrome Cases amid COVID-19 to Boost Growth

The recent spike in the cases of people suffering from the novel coronavirus disease is expected to surge the cardiac syndrome risk amongst people susceptible to contracting it. This is leading the pharmaceutical sector to focus on developing advanced vasopressin drugs for treatment purposes. This is expected to bode well for the growth of the global market in the near future.

Vasoplegia is a type of syndrome that involves pathologically low systemic vascular resistance. It further leads to reduced blood pressure amid presence of a raised cardiac output. The growing adoption of vasopressin for vasoplegic shock treatment is gaining popularity owing to its efficiency in treating the syndrome.

Quick Buy –  Vasopressin for Vasoplegic Shock Market Research Report:

Table Of Content :

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Recent Industry Developments Such as Mergers & Acquisitions
    • Regulatory Scenario for Key Countries
    • New Product Launch
    • Statistics on Prevalence of Cardiac Disorders for Key Countries/Regions
    • Pipeline Analysis



Increasing Incidence of Cardiovascular Surgeries to Augment Growth

According to the Centers for Disease Control and Prevention (CDC), every year about 340,000 Coronary Artery Bypass Grafting (CABG) procedures are performed in the U.S. The increasing number of cardiovascular surgeries propels the demand for vasopressin to control the blood flow. Additionally, the growing number of CABG procedures and sepsis patients are boosting the demand for innovative vasopressin treatment options. This is expected to bode well for the global vasopressin for vasoplegic shock market growth during the forecast period.


Post Cardiac Surgery Segment Held 25.2% in 2019

The post cardiac segment, based on application, held a market share of about 25.2% in 2019 and is likely to gain momentum owing to the increasing number of cardiac surgeries that require efficient post-cardiac treatment globally.


Increasing Prevalence of Sepsis in North America to Favor Growth

Among all the regions, North America stood at USD 561.3 million in 2019 and is expected to hold the highest position in the global market in the forthcoming years. This is ascribable to the increasing prevalence of sepsis that drives the demand for advanced vasopressin for vasoplegic shock treatment procedures in the region.

The market in Europe is expected to experience a significant growth backed by surging investments in R&D by the government as well as major companies to develop advanced vasopressin for vasoplegic shock treatment between 2020 and 2027.


Prominent Companies Focus on Investment in R&D Activities to Develop Innovative Vasopressin for Vasoplegic Shock

The global vasopressin for vasoplegic shock market is fragmented by the presence of key players that are focusing on raising investments to develop advanced vasopressin for vasoplegic shock treatment. Additionally, the major companies are striving to maintain their presence in the global marketplace by adopting strategies such as partnership, collaboration, and merger and acquisition to gain a competitive edge over their rivals during the forecast period.

Industry Development:

  • April 2018 – Eagle Pharmaceuticals, Inc announced the approval of its new drug application, ANDA for 1ml vasopressin injection. The product is a original generic version of Endo International plc’s Vasostrict formulation.

List of the Companies Profiled in the Market:

  • Endo International plc (Dublin, Ireland)
  • AMOMED Pharma (Vienna, Austria)
  • La Jolla Pharmaceutical Company (California, U.S.)
  • Pfizer Inc. (New York, U.S.)
  • Ferring Pharmaceuticals (Saint-Prex, Switzerland)
  • Fresenius Kabi Canada (Toronto, Canada)
  • Astellas Pharma (Tokyo, Japan)
  • Eagle Pharmaceuticals, Inc. (New Jersey, U.S.)
  • Others

Have Any Query? Ask Our Experts:

Global Vasopressin for Vasoplegic Shock Market Segmentation :

By Application

  • Sepsis
  • Post Cardiac Surgery
  • Others

By Geography

  • North America
    • By Application
    • By Country
  • Europe
    • By Application
    • By Country/Sub-region
  • Asia Pacific
    • By Application
    • By Country/Sub-region
  • Latin America
    • By Application
    • By Country/Sub-region
  • The Middle East & Africa
    • By Application
    • By Country/Sub-region


More Trending Topics from Fortune Business Insights :

Dermatology Drugs Industry to Exhibit a CAGR of 12.9% by 2027; Growing Inclination towards Skin Care and Health to Brighten Possibilities, states Fortune Business Insights™

Dental Equipment Industry to Reach USD 16.07 Billion by 2027; Increasing Adoption of Digital Dental X-Ray Equipment to Stoke Demand: Fortune Business Insights™

Australia and New Zealand Prothrombin Complex Concentrate Market

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: [email protected]


Related Reports :

Dentures Market to Reach USD 3.82 Billion by 2027 on Account of Rise in Baby Boomer Population

Nicotine Replacement Therapy (NRT) Market Worth USD 3.54 Billion at 4.2% CAGR; Increasing Cases of Smoking Cessation in North America to Stoke Exponential Demand

Immune Health Supplements Market to Reach USD 29.40 Billion by 2027; High Demand for Organic & Non-GMO Products to Boost Growth

Bovine Mastitis Market to Reach $1.84Billion by 2027; Rising Incidence of the Disease in Several Parts of the World will Aid Growth, says Fortune Business Insights™

Peptic Ulcer Drugs Market Worth USD 5.13 Billion at 2.4% CAGR by 2027; Increasing Incidence of Peptic Ulcers Worldwide to Surge Demand: Fortune Business Insights™

Oncology Drugs Market to Benefit Strongly; Rising Incidence of Lung Cancer to Aid Development, states Fortune Business Insights™

Artificial Tears Market to Reach USD 4.30 Billion by 2027; Increasing Knowledge about Conjunctivitis and Other Eye Disorders to Foster Growth, states Fortune Business Insights™


Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *